Warning letter
Naturavit, Inc.: warning letter of Aug 27, 2012
FDA warning letter 295037 · Florida District Office
Key facts
| Reference number | 295037 |
|---|---|
| Company | Naturavit, Inc. |
| Subject | CGMP For Manufacturing, Packing, Labeling, or Holding for Dietary Supplements/Adulterated/Misbranded |
| Issue date | Aug 27, 2012 |
| Posted date | Aug 27, 2012 |
| Issuing office | Florida District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.255(a), 111, 111.14, 111.103, 111.140, 111.455, 111.465, 111.503, 111.510, 111.553, 111.410(b), 111.430(b) and 12 more |
| Inspection city | Miami |
| Inspection ZIP | 33186 |
| Inspection start date | Feb 27, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: